FDA approves Moderna’s mRNA flu vaccine

The Food and Drug Administration on Wednesday approved the first mRNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or particularly virulent strain of the virus.

See the original article at: Honolulu Star-Advertiser